Interestingly, work has shown a role for OKA in promoting AD-like neuropathology [119] by selectively inhibiting protein phosphatases PP1 and PP2A, which promotes hyper-phosphorylation of tau [49]. The gene discussed is MAPT; the disease is Alzheimer disease.